Tisolagiline is a MAOB Inhibitor for Parkinson’s Diseases Research
Parkinson’s disease (PD) is the second common progressive neurodegenerative disorder next to Alzheimer’s disease. The pathological hallmark of Parkinson’s disease includes progressive loss of dopaminergic cells present in the substantia…